Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Lupin Limited NSE India S.E.

Equities

LUPIN

INE326A01037

Market Closed - NSE India S.E.
Other stock markets
 07:43:55 2024-06-28 am EDT 		5-day change 1st Jan Change
1,621 INR +2.40% Intraday chart for Lupin Limited +4.22% +22.56%
Jun. 28 India plans incentives for diabetes, obesity drug makers in 2026, government official says RE
Jun. 28 Indian Equities Fall on Friday, Dragged Mainly by Banking Stocks MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
India plans incentives for diabetes, obesity drug makers in 2026, government official says
RE
Indian Equities Fall on Friday, Dragged Mainly by Banking Stocks
MT
Lupin Loses Appeal Against EU Anti-Trust Fine
MT
Lupin : June 27, 2024 Lupin Receives Tentative Approval from U.S. FDA for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
PU
Lupin : June 22, 2024 Lupin Receives EIR from U.S. FDA for its Somerset Manufacturing Facility
PU
Lupin : June 17, 2024 Lupin Appoints Abdelaziz Toumi as CEO of its API CDMO Subsidiary
PU
Lupin Appoints CEO for Subsidiary Lupin Manufacturing Solutions
MT
Lupin : June 14, 2024 Lupin Announces Closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations
PU
Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection
MT
Lupin : June 12, 2024 Lupin and Fuji Sign License and Supply Agreement for Commercialization of Nextstellis™ in Vietnam and Philippines
PU
Lupin : June 5, 2024 Lupin Completes Acquisition of two Brands from Sanofi in Europe and Canada
PU
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada
MT
Lupin : June 3, 2024 Lupin Receives Tentative Approval from U.S. FDA for Letermovir Tablets
PU
Lupin : June 3, 2024 Lupin Launches Doxycycline for Injection USP in the United States
PU
India's pharma export sales to grow faster this year, trade body says
RE
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
RE
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection
MT
U.S. FDA Concludes a Pre Approval Inspection at Lupin's Somerset, New Jersey Manufacturing Facility
CI
Lupin : May 16, 2024 Lupin Receives Approval from U.S. FDA for Midostaurin Capsules
PU
Lupin : May 15, 2024 Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. LUPIN Stock
  5. News Lupin Limited